Can a dual energy catheter tame dangerous heart rhythms?

NCT ID NCT07727057

Recruiting now Disease control Sponsor: Biosense Webster, Inc. Source: ClinicalTrials.gov ↗

First seen Jul 27, 2026 · Last updated Aug 11, 2026 · Updated 4 times

Summary

This trial investigates whether a new dual energy catheter system can safely and effectively treat ventricular arrhythmias—abnormal heart rhythms that can be life-threatening. The system uses both radiofrequency and pulsed field energy to ablate the heart tissue causing the problem. Researchers will track how well the procedure reduces arrhythmia burden and monitor for complications within the first week.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a dual energy catheter system that delivers radiofrequency and pulsed field ablation to treat abnormal heart rhythms
What this could lead to: If successful, this could offer a more effective and safer way to treat ventricular arrhythmias, potentially reducing the need for repeat procedures.
What could go wrong: This is an early-stage workflow study with a small number of participants. The procedure carries risks such as heart damage, stroke, or bleeding, and the results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMIAS, CARDIAC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac cardiac rhythm disease ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARRHYTHMIAS, CARDIAC

Contacts and locations

Locations

AZ Sint-Jan Brugge
NOT_YET_RECRUITING

Bruges, 8000, Belgium
AZORG campus Aalst Moorselbaan
RECRUITING

Aalst, 9300, Belgium
CHU de Bordeaux - Hospital Haut-Leveque
WITHDRAWN

Pessac, 33600, France
CHU de Clermont Ferrand
NOT_YET_RECRUITING

Clermont-Ferrand, 63000, France
Inselspital
NOT_YET_RECRUITING

Bern, CH-3010, Switzerland
Medizinische Universitat Graz
NOT_YET_RECRUITING

Graz, 8036, Austria
Ordensklinikum Linz GmbH Elisabethinen
NOT_YET_RECRUITING

Linz, 4020, Austria
RHÖN-KLINIKUM Campus Bad Neustadt
NOT_YET_RECRUITING

Bad Neustadt an der Saale, 97616, Germany
TUM Klinikum Deutsches Herzzentrum
NOT_YET_RECRUITING

München, 80636, Germany
Universitatsspital Zurich
NOT_YET_RECRUITING

Zurich, 8091, Switzerland
University Hospital of the Ruhr-University of Bochum
NOT_YET_RECRUITING

Bad Oeynhausen, 32545, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.